As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Antiplatelet Drugs Market: By Drug: Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dipyridamole, Ticlopidine, Abciximab, Tirofiban; By Drug Class; By Application; By Route of Administration; By Distributional Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global Antiplatelet Drugs Market Outlook

The global antiplatelet drugs market is expected to grow at a CAGR of 7% in the forecast period of 2022-2027.

 

Global Antiplatelet Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Dominate the Global Antiplatelet Drugs Industry

North America is the leading region in the global market for antiplatelet drugs. The region accounts for a significant share in the industry owing to the increasing penetration of key players in the region and the growing investments in clinical trials for antiplatelet drugs. Further, the presence of a large number of patients suffering from myocardial infarction and ischaemic strokes across the region is also aiding the industry growth. In the United States, around 800,000 individuals suffer from stroke every year, out of which 87% are ischaemic strokes. Thus, the growing prevalence of these diseases is leading to an increased demand for antiplatelet drugs. Meanwhile, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the rising investments in R&D activities and the increasing government initiatives to reduce the number of deaths caused by thrombotic cardiovascular disease.

 

Antiplatelet Drugs: Industry Definition and Segmentation

Antiplatelet drug belongs to a class of pharmaceuticals that decrease platelet aggregation, thus, preventing the formation of thrombus. These drugs are often referred to as platelet aggregation inhibitors. They help prevent blood cells (platelets) from clumping together to form a clot, thereby, decreasing the formation of potentially harmful blood clots. They show high efficacy in the arterial circulation, where anticoagulants are less effective. Antiplatelet drugs are most commonly used in primary and secondary prevention of thrombotic cerebrovascular or cardiovascular disorder.

 

Global Antiplatelet Drugs Market By Distribution Channel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By drug, the market is divided into:

  • Aspirin
  • Clopidogrel
  • Ticagrelor
  • Prasugrel
  • Dipyridamole
  • Ticlopidine
  • Abciximab
  • Tirofiban
  • Others

On the basis of drug class, the industry can be segmented into:

  • Platelet Aggregation Inhibitors
  • Glycoprotein Platelet Inhibitors
  • Protease-Activated Receptor-1 Antagonists
  • Others

Based on applications, the industry can be categorised into:

  • Myocardial Infraction
  • Percutaneous Coronary Interventions
  • Angioplasty
  • Arterial Thrombosis
  • Dental Surgeries
  • Others

The different routes of administration of antiplatelet drugs are:

  • Oral
  • Injectable

The various distribution channels of the product are:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Antiplatelet Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Advancements in the Pharmaceuticals Sector and the Growing Prevalence of Thrombosis to Bolster the Growth of the Antiplatelet Drugs Industry

The global market for antiplatelet drugs is being driven by the advancements in the pharmaceutical industry and the increasing cases of thrombosis, both arterial and venous. The incidences of venous thrombosis have escalated rapidly in the twenty-first century. Further, in patients with certain medical conditions, prevention and treatment of arterial thrombosis is particularly essential, as it can increase the chances of thrombosis or thromboembolism, which may lead to heart attack, pulmonary embolism, or stroke. Treatment of established arterial thrombosis involves the utilisation of antiplatelet drugs and thrombolytic therapy. These drugs are also essential for an individual who has undergone a heart surgery (especially prosthetic replacement heart valve). Thus, an increase in the number of patients undergoing heart surgery is also aiding the market growth. Other factors like increasing sedentary lifestyles, the proliferation of anticoagulant/antithrombotic drugs, rising geriatric population, and favourable government initiatives are further propelling the industry forward. Over the forecast period, the increasing R&D activities are expected to further contribute to the industry growth.

 

Key Industry Players in the Global Antiplatelet Drugs Market

The report gives a detailed analysis of the following key players in the global antiplatelet drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Glenmark Pharmaceuticals Ltd.
  • Sanofi SA
  • Pfizer Inc.
  • Baxter International Inc.
  • Bayer AG
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug, Drug Class, Application, Route of Administration, Distributional Channel, Region
Breakup by Drug Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dipyridamole, Ticlopidine, Abciximab, Tirofiban, Others
Breakup by Drug Class Platelet Aggregation Inhibitors, Glycoprotein Platelet Inhibitors, Protease-Activated Receptor-1 Antagonists, Others
Breakup by Application Myocardial Infraction, Percutaneous Coronary Interventions, Angioplasty, Arterial Thrombosis, Dental Surgeries, Others
Breakup by Route of Administration Oral, Injectable
Breakup by Distributional Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Glenmark Pharmaceuticals Ltd., Sanofi SA, Pfizer Inc., Baxter International Inc., Bayer AG, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Antiplatelet Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Antiplatelet Drugs Historical Market (2017-2021) 
    8.3    Global Antiplatelet Drugs Market Forecast (2022-2027)
    8.4    Global Antiplatelet Drugs Market by Drug 
        8.4.1    Aspirin
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Clopidogrel
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Ticagrelor
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Prasugrel
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Dipyridamole
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
        8.4.6    Ticlopidine
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2017-2021)
            8.4.6.3    Forecast Trend (2022-2027)
        8.4.7    Abciximab
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2017-2021)
            8.4.7.3    Forecast Trend (2022-2027)
        8.4.8    Tirofiban
            8.4.8.1    Market Share
            8.4.8.2    Historical Trend (2017-2021)
            8.4.8.3    Forecast Trend (2022-2027)
        8.4.9    Others
    8.5    Global Antiplatelet Drugs Market by Drug Class
        8.5.1    Platelet Aggregation Inhibitors
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Glycoprotein Platelet Inhibitors
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Protease-Activated Receptor-1 Antagonists
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Others
    8.6    Global Antiplatelet Drugs Market by Application
        8.6.1    Myocardial Infraction
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Percutaneous Coronary Interventions
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Angioplasty
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Arterial Thrombosis
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Dental Surgeries
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021)
            8.6.5.3    Forecast Trend (2022-2027)
        8.6.6    Others
    8.7    Global Antiplatelet Drugs Market by Route of Administration
        8.7.1    Oral
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Injectable
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
    8.8    Global Antiplatelet Drugs Market by Distributional Channel
        8.8.1    Hospital Pharmacy
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2017-2021)
            8.8.1.3    Forecast Trend (2022-2027)
        8.8.2    Retail Pharmacy
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2017-2021)
            8.8.2.3    Forecast Trend (2022-2027)
        8.8.3    Online Pharmacy
            8.8.3.1    Market Share
            8.8.3.2    Historical Trend (2017-2021)
            8.8.3.3    Forecast Trend (2022-2027)
        8.8.4    Others
    8.9    Global Antiplatelet Drugs Market by Region
        8.9.1    Market Share
            8.9.1.1    North America
            8.9.1.2    Europe
            8.9.1.3    Asia Pacific
            8.9.1.4    Latin America
            8.9.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Glenmark Pharmaceuticals Ltd.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Sanofi SA
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Pfizer Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Baxter International Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Bayer AG
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Antiplatelet Drugs Market: Key Industry Highlights, 2016 and 2026
2.    Global Antiplatelet Drugs Historical Market: Breakup by Drug (USD Million), 2017-2021
3.    Global Antiplatelet Drugs Market Forecast: Breakup by Drug (USD Million), 2022-2027
4.    Global Antiplatelet Drugs Historical Market: Breakup by Drug Class (USD Million), 2017-2021
5.    Global Antiplatelet Drugs Market Forecast: Breakup by Drug Class (USD Million), 2022-2027
6.    Global Antiplatelet Drugs Historical Market: Breakup by Application (USD Million), 2017-2021
7.    Global Antiplatelet Drugs Market Forecast: Breakup by Application (USD Million), 2022-2027
8.    Global Antiplatelet Drugs Historical Market: Breakup by Distributional Channel (USD Million), 2017-2021
9.    Global Antiplatelet Drugs Market Forecast: Breakup by Distributional Channel (USD Million), 2022-2027
10.    Global Antiplatelet Drugs Historical Market: Breakup by Region (USD Million), 2017-2021
11.    Global Antiplatelet Drugs Market Forecast: Breakup by Region (USD Million), 2022-2027
12.    North America Antiplatelet Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
13.    North America Antiplatelet Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Europe Antiplatelet Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Europe Antiplatelet Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Asia Pacific Antiplatelet Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Asia Pacific Antiplatelet Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Latin America Antiplatelet Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Latin America Antiplatelet Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Middle East and Africa Antiplatelet Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Middle East and Africa Antiplatelet Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Global Antiplatelet Drugs Market Structure

Key Questions Answered in the Report

The global antiplatelet drugs market is projected to grow at a CAGR of 7% between 2021 and 2026.

The major drivers of the industry, such as the advancements in the pharmaceutical sector, increasing prevalence of thrombotic cardiovascular disease, increasing geriatric population, proliferation of anticoagulant/antithrombotic drugs, favourable government initiatives, and busy lifestyles, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing investments by the key players in the research and development of antiplatelet drugs.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading drugs in the market are aspirin, clopidogrel, ticagrelor, prasugrel, dipyridamole, ticlopidine, abciximab, and tirofiban, among others.

The major drug classes in the industry are platelet aggregation inhibitors, glycoprotein platelet inhibitors, and protease-activated receptor-1 antagonists, among others.

The significant application segments in the market are myocardial infraction, percutaneous coronary interventions, angioplasty, arterial thrombosis, and dental surgeries, among others.

The leading routes of administration of antiplatelet drugs in the industry are oral and injectable.

The major distribution channels in the market are hospital pharmacy, retail pharmacy, and online pharmacy, among others.

The major players in the industry are Glenmark Pharmaceuticals Ltd., Sanofi SA, Pfizer Inc., Baxter International Inc., and Bayer AG, among others.

Analyst Review

The global antiplatelet drugs market is being driven by the rising prevalence of thrombotic cardiovascular disease. Aided by the favourable government initiatives , the market is expected to witness a healthy growth in the forecast period of 2022-2027, growing at a CAGR of 7%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug, the market is segmented into aspirin, clopidogrel, ticagrelor, prasugrel, dipyridamole, ticlopidine, abciximab, and tirofiban, among others. By drug class, the industry is divided into platelet aggregation inhibitors, glycoprotein platelet inhibitors, and protease-activated receptor-1 antagonists, among others. On the basis of applications, the market is categorised into myocardial infraction, percutaneous coronary interventions, angioplasty, arterial thrombosis, and dental surgeries, among others. Based on routes of administration, the industry is segmented into oral and injectable. By distribution channels, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy, among others. The major regional markets for antiplatelet drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Glenmark Pharmaceuticals Ltd., Sanofi SA, Pfizer Inc., Baxter International Inc., and Bayer AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER